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1Case Number 1
Familial Adenomatous Polyposis
John Xuereb and Yana Marie Dimech 
Reviewed by: Mr. Dennis T. Gatt L.R.C.P.(Lond.), F.R.C.S.(Eng.), F.R.C.S.(Edin.)
Case summary:
Demographic details:
Ms. OC, female, 17 years.
Referred from: home due to strong family history. 
OC, a 17-year-old female, was referred due to a strong family history of Familial Adenomatous Polyposis. 
Multiple relatives (mother, two uncles, several cousins and others) have had Familial Adenomatous 
Polyposis and had undergone proctocolectomy to prevent the benign polyps from undergoing malignant 
transformation. The patient presented with no signs and symptoms. On colonoscopy, multiple polyps were 
found at 10 cm, 15 cm, 40 cm, 80 cm, 110 cm and even in the caecum. The patient subsequently underwent 
elective Restorative Proctocolectomy with an Ileal Pouch Reservoir. No defunctioning ileostomy was 
created but the patient was instead managed on TPN (Total Parenteral Nutrition) post-operatively for 2 
weeks until a gastrografin small bowel study confirmed the integrity of the pouch and the anastomosis. 
The patient will be followed up by means of yearly pouchoscopy to exclude the possibility of malignant 
change at the Transitional Zone between the anal canal and the pouch.
Presenting complaint:
The patient was admitted for elective restorative proctocolectomy with an ileal pouch, after being 
diagnosed with Familial Adenomatous Polyposis on colonoscopy. 
History of presenting complaint:
The patient has a strong family history of Familial Adenomatous Polyposis. She presented with no signs 
and symptoms. She complains of no bleeding per rectum, no nausea, no abdominal pain, no pyrexia 
and no change in bowel habits. Despite the presence of so many polyps in her colon she passed stools 
regularly with no changes in frequency, colour and consistency.
Past medical and surgical history:
Past medical history:
• Sinusitis 
• Allergic Rhinitis 
Past surgical history:
• Tonsillectomy and Adenoidectomy (16/02/2001)
2Drug history:
Nil to note.  No known drug allergies.
Family history:
OC has a strong family history of Familial Adenomatous Polyposis. Multiple relatives; including her 
mother, two uncles, several cousins and other distant relatives have had Familial Adenomatous Polyposis 
and were operated upon, on confirmation of the diagnosis.
Social history:
Patient still lives with her parents. She has stopped attending school after her O-levels and is currently 
working at Methode Electronics Malta Ltd. 
The patient is a social drinker and does not smoke or make use of recreational drugs. 
 
Systemic inquiry:
• General Health: Good and active. Patient looked comfortable after operation
• Cardiovascular System: Nil to note
• Respiratory System: Allergic Rhinitis and Sinusitis
• Gastrointestinal Tract: Nil to note 
• Genitourinary System: Nil to note
• Central Nervous System: Headaches associated with sinusitis
• Musculoskeletal System: Nil to note
• Endocrine System: Nil to note
Discussion of results of general and specific examination:
General examination of the patient was unremarkable. The patient appeared healthy, with no physical 
signs and symptoms of Familial Adenomatous Polyposis. The patient was not pale, jaundiced or cyanosed. 
There were no evident signs of recent weight loss and the patient denied recent rapid weight loss. She 
was afebrile.
Cardiovascular, respiratory and abdominal examinations were also unremarkable. These revealed normal 
heart sounds S1+S2+0, with equal air entry in both lungs and normal vesicular breath sounds. On the 
abdomen no swelling or scars were observed. The abdominal examination did not reveal any masses or 
organomegaly.  There was no guarding or rebound tenderness. Normal bowel sounds were auscultated 
and stools were normal.
Differential diagnosis:
• MUTYH associated polyposis (MAP)
• Juvenile polyposis
• Peutz-Jeghers Syndrome 
• Mixed Adenomatous hyperplastic Polyposis
• Hyperplastic Polyposis syndrome 




Justification for test: Strong family history of Familial Adenomatous Polyposis.
Results: Multiple polyps at 10 cm, 15 cm, 40 cm, 80 cm, 110 cm and the caecum. More than 30 polyps 
were present at 80 cm. 
Conclusion: Morphology suggestive of Familial Adenomatous Polyposis.
    
Figures 1 and 2: Colonoscopy showing multiple polyps.
Laboratory exams:
Test: Biopsy for histology from colonoscopy. 
Justification for test: Multiple polyps on colonoscopy. 
Results: Biopsies from colon at 100 cm show portion of normal colonic mucosa with a single small area 
of crypt epithelial hyperplasia resembling edge of hyperplastic polyp. 
Biopsies from colon at 90 cm, 40 cm, 15 cm and 10 cm all show portions of colonic mucosa with areas 
of mild crypt epithelial dysplasia, resembling low grade tubular adenoma. There is no evidence of severe 
dysplasia or other abnormal feature of note. 
Conclusion: The colon at 100 cm shows hyperplastic polyp while the colon at 90 cm, 40 cm, 15 cm and 
10 cm shows low grade tubular adenoma.
Test: Proctocolectomy bowel specimen sections for histology.
Justification of test: To confirm diagnosis and exclude high grade dysplasia or invasive adenocarcinoma 
after restorative proctocolectomy with ileal pouch-anal anastomosis.
Results: Sections from proctocolectomy specimen showed multiple small tubular adenomas with low 
grade dysplasia. Numerous prominent lymphoid follicles were also present. There was no evidence of 
high grade dysplasia or invasive adenocarcinoma. Sections from small bowel were unremarkable. Both 
surgical margins were unremarkable. All of the twenty retrieved lymph nodes show sinus histiocytosis 
and reactive follicular hyperplasia. 
Conclusion: Multiple tubular adenomas with low grade dysplasia, typical of Familial Adenomatous 
Polyposis and reactive lymph nodes, typical of inflammatory and immune reactions, were diagnosed.
4Therapy:
Surgical therapy:
Pre-operative: The patient was admitted to the surgical wards from admission lounge a day before the 
surgery. The patient was started on Klean prep, for bowel cleansing. Four sachets were taken in total, one 
sachet with one litre of water every two hours. The patient was allowed fluids for that day but then nil 
by mouth from midnight. TED stockings were applied. An ECG and cross-match were carried out. Stool 
charting was started. Informed consent was obtained.
Operation: Restorative proctocolectomy with ileal pouch-anal anastomosis. 
Total mobilisation of the colon including; the caecum, ascending colon, transverse colon, splenic flexure, 
descending colon, sigmoid colon and the rectum was performed. The dissection at the pelvic brim was 
carried out, very close to the colon to preserve the Nervi Erigentes. The rectum was dissected by a 
combination of blunt and sharp dissection, all the way down to the pelvic floor and transected with a 
Contour Stapler. The terminal ileum was also divided at this stage, with a GIA stapler. A 35 cm Ileal 
Pouch Reservoir was created from the terminal ileum in a J shape using 3 firings of the GIA stapler. The 
lower end of the J was then anastomosed to the anal canal using a CEA 28 stapler and the doughnuts were 
inspected to make sure they were not broken. The abdomen was closed with drainage to the pelvis and no 
defunctioning ileostomy was used. 
A central venous catheter was also inserted during the operation for Total Parenteral Nutrition (TPN). The 
right jugular vein was used.  
Post-operative: A naso-gastric tube was inserted. Total Parenteral Nutrition was started three days after 
surgery; when serum potassium, calcium, magnesium and phosphates were all in normal ranges. The 
abdominal drainage was minimal on the fourth day following surgery. The patient was also passing flatus 
and greenish liquid stools on the fourth day following surgery.
The post-operative medications were as follows:
Drug Name (Generic) Dosage Route Frequency Reason
Paracetamol 1 g IV/PO/PR 4-6 hrly / PRN Pain relief
Ciprofloxacin 200 mg IV BD Broad spectrum antibiotic 
(prophylaxis)
Metronidazole (Flagyl) 500 mg IV TDS Prophylaxis against 
anaerobic organisms and 
protozoa
Diclofenac (Voltaren) 500 mg PO PRN Pain relief
Magnesium sulphate 50% 2 mls in 100 mls 
normal saline
IV BD Acts as a supplementary 
analgesic therapy to 
suppress the acute post-
operative pain
Clexane 4000 units SC QD Prophylaxis for deep 




12.5 mg IM PRN To control nausea and 
vomiting post-operatively
Pethidine 50 mg IM PRN Pain relief
5Diagnosis:
Familial Adenomatous Polyposis was diagnosed by means of colonoscopy and histological examination 
of the biopsies taken from the various polyps found. The colonoscopy was indicated because of the strong 
family history. The diagnosis was then confirmed after restorative proctocolectomy by more detailed 
histological evaluation of the entire colonic specimen. In this case, high grade dysplasia and invasive 
adenocarcinoma were also excluded.    
Familial Adenomatous Polyposis (FAP) is classically characterised by the development of numerous 
polyps (polyposis) in the colon and rectum at atypical early ages, usually during the second decade of 
life1-2. This condition carries a 100% lifetime risk of malignant transformation of adenomas into colorectal 
carcinoma3. FAP is inherited as an autosomal dominant disease caused by the germ-line mutation of the 
APC (Adenomatous Polyposis Coli) gene4.   
FAP is typically asymptomatic, especially in children and adolescents, until the polyps are large and 
numerous sufficiently to start causing rectal bleeding, constipation, diarrhoea, change in bowel habits or 
abdominal pains. Some patients also evolve palpable abdominal masses and weight loss. Many patients 
remain asymptomatic until they develop colorectal carcinoma (CRC)2. 
On colonoscopy, classic FAP presents with hundreds and thousands of colorectal adenomatous polyps. 
These typically start to develop in early childhood, predominately at the rectosigmoid and later on, in 
adolescence, these are typically established throughout the colon2. It is shown that at 15 years of age 50% 
of the patients have established adenomas while at 35 years of age up to 95% have developed adenomas5. 
Though colorectal carcinoma in the majority of cases develops by the age 40-50 years it can still develop 
in children2. 
FAP patients also commonly present with extra-colonic gastrointestinal features. These include fundic 
gland polyps in the stomach, adenomatous polyps in the duodenum and periampullary region and small 
bowel adenoma2. Fundic gland polyps have the potential to progress to carcinoma but rarely do so6. 
About 5% of adenomatous polyps in the duodenum and periampullary region progress to malignancy in 
a 10-year period7. Small bowel polyps also carry a risk for malignant transformation though this is lower 
than the risk in duodenal and ampullary neoplasm2.   
     
FAP may also present with any of its extraintestinal manifestations. These include congenital hypertrophy 
of the retinal pigment epithelium, dental abnormalities (including supenumerary teeth, congenital absence 
of one or more teeth and unerupted teeth), osteomas, desmoid tumours and extracolonic cancers (including 
thyroid, liver, bile ducts and central nervous system tumours). Gardner’s syndrome is a clinical variant of 
FAP where the extra-colonic features are prominent2.   
A milder form of FAP can present, Attenuated FAP, is a less aggressive variant where one develops fewer 
adenomas and the adenomas and colorectal carcinoma both develop at a later age2. 
Nearly every patient with FAP will develop colorectal carcinoma if they are undiagnosed or untreated. 
However, at present it is very atypical to find patients presenting with symptoms of the colorectal 
carcinoma since most of the patients today are diagnosed and treated surgically before there is malignant 
transformation2.  
A high clinical index of suspicion is needed as patients are usually asymptomatic but may present with a 
strong family history. Questions such as; whether anyone in the family ever had cancer, what type of cancer 
and at what age it presented are vital in this case. One may also identify extra-colonic manifestations of 
FAP, on which grounds a physician should perform a flexible sigmoidoscopy or a colonoscopy. Genetic 
testing is also of use in FAP. Its main role is in screening and in the early asymptomatic stages of the 
6disease in patients with a strong family history. Numerous types of genetic tests are currently available 
to investigate for APC germline mutations. Direct sequencing of the APC gene is the preferred and most 
commonly used method at present2.     
The aim of management in FAP patients is tumour prevention while maintaining a good quality of 
life. This is usually obtained, after their genetic diagnosis and endoscopic procedures, by prophylactic 
colorectal surgery. Since colorectal carcinoma is rare in asymptomatic children and adolescents, these 
should be followed up and then at around 16 -18 years of age an elective procedure is planned8. Multiple 
surgical options are available. These include; subtotal colectomy with ileorectal anastomosis (IRA), total 
proctocolectomy with ileostomy and proctocolectomy with or without mucosectomy and ileal pouch anal 
anastomosis (IPAA).The latter procedure is preferred for classical FAP, especially if numerous rectal 
adenomas are present 9,10. 
Post-operatively it is crucial to follow-up these patients. Initially, one should deal with the physical and 
psychological adjustments to surgery and identifying desmoid tumour formation which is associated with 
FAP2. In IRA, due to the risk of rectal adenomas and carcinomas, life-long rectal endoscopic investigations 
should be carried out annually. Also, studies have shown that after restorative proctocolectomy, adenomas 
and even adenocarcinomas can evolve in the ileo-anal pouch and the transitional anal zone. Therefore it 
is vital to undertake endoscopic surveillance of both the pouch11 and the transitional anal zone12.
Final treatment and follow ups:
The patient was kept nil by mouth until a small bowel gastrografin enema was carried out and this 
confirmed that the pouch and the anastomosis were intact.  At this stage she was started on a light diet 
and the total parenteral nutrition was stopped 17 days post-operatively. 
The patient will be followed up by means of yearly pouchoscopy, to exclude the possibility of malignant 
change at the Transitional Zone between the anal canal and the pouch.
7Fact Box 1
Title: Familial Adenomatous Polyposis
Familial Adenomatous Polyposis (FAP) is an inherited autosomal dominant disease4. It classically 
characterised by the development of numerous polyps (polyposis) in the colon and rectum at atypical 
early ages, usually during the second decade of life1-2. FAP is caused by the germ-line mutation of the 
APC (Adenomatous Polyposis Coli) gene4. This condition carries a 100% lifetime risk of malignant 
transformation of adenomas into colorectal carcinoma3. 
Signs and symptoms:  FAP is typically asymptomatic until patients develop colorectal carcinoma (CRC).
In some cases, especially after adolescence, when polyps are large and numerous sufficiently, symptoms 




• Change in bowel habits
• Abdominal pains
• Palpable abdominal masses
• Weight loss
Risk  factors: Family history 
Investigations to confirm diagnosis:2
• Flexible sigmoidoscopy or colonoscopy 
• Biopsy for histology 
• Genetic testing 
Prevention of Colorectal carcinoma:9,10
• Subtotal colectomy with ileorectal anastomosis (IRA) 
• Total proctocolectomy with ileostomy 
• Proctocolectomy with or without mucosectomy and ileal pouch anal anastomosis (IPAA)
The latter procedure is preferred for classical FAP, especially if numerous rectal adenomas are present.
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